Moskin Comments on Case Challenging Constitutionality of Ban on Registration for Offensive Trademarks
24 April 2019
Westlaw Journal Intellectual Property
Partner Jonathan Moskin was quoted in a Westlaw Journal Intellectual Property article, “Justices question if ‘Fuct’ trademark merits First Amendment protection,” about a pending Supreme Court case addressing the constitutionality of a statute prohibiting trademark registration for offensive trademarks.
Moskin noted a distinction between the statute’s prohibition of disparaging and scandalous marks. “Because the statutory provision does not bar offensive ideas, but merely how they are expressed, the statutory provision is more nearly viewpoint-neutral, and hence more likely to withstand scrutiny,” he said.
Moskin noted a distinction between the statute’s prohibition of disparaging and scandalous marks. “Because the statutory provision does not bar offensive ideas, but merely how they are expressed, the statutory provision is more nearly viewpoint-neutral, and hence more likely to withstand scrutiny,” he said.
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."